SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-21-048130
Filing Date
2021-09-15
Accepted
2021-09-15 06:20:38
Documents
1
Group Members
C-LSH II LLCCASDIN CAPITAL, LLCCASDIN PARTNERS GP, LLCCASDIN PARTNERS MASTER FUND, L.P.ELI CASDINKEITH A. MEISTERM-LSH II LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea147401-13dcmls2_somalogic.htm SC 13D 153533
  Complete submission text file 0001213900-21-048130.txt   155406
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Subject) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92455 | Film No.: 211254180
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065
Business Address 667 MADISON AVENUE C/O CORVEX MANAGEMENT LP NEW YORK NY 10065 (212) 474-6724
CMLS Holdings II LLC (Filed by) CIK: 0001845781 (see all company filings)

IRS No.: 000000000
Type: SC 13D